Inclusion completed

Dendritic cell vaccination in combination with Docetaxel for patients with prostate cancer – a randomized phase II study

Cancer type: Prostate cancer

Phase: II

Principal Investigator: Svane Inge Marie

Country: DK

Keywords: Denmark, Herlev, Prostate cancer, dendritic cell vaccination, Docetaxel

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01446731?term=NCT01446731&rank=1